img

Global Famciclovir Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Famciclovir Market Insights, Forecast to 2034

Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.
Global Famciclovir market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Famciclovir industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Famciclovir key manufacturers include Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals and Beijing Jialin Pharmaceutical, etc. Novartis, Mylan, Teva are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Famciclovir were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Famciclovir market and estimated to attract more attentions from industry insiders and investors.
Famciclovir can be divided into 125 mg Tablets, 250 mg Tablets and 500 mg Tablets,, etc. 125 mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Famciclovir is widely used in various fields, such as Cold Sores, Genital Herpes and Shingles,, etc. Cold Sores provides greatest supports to the Famciclovir industry development. In 2022, global % sales of Famciclovir went into Cold Sores filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Famciclovir market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Famciclovir market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Mylan
Teva
Cipla
Hikma
Apotex
Aurobindo Pharma
Macleods Pharmaceuticals
Beijing Jialin Pharmaceutical
HETERO
Hainan choitec Pharmaceuticals
Shandong Luoxin Pharmaceutical Group
Chengdu Diao Pharmaceutical Group
HISUN
Segment by Type
125 mg Tablets
250 mg Tablets
500 mg Tablets

Segment by Application


Cold Sores
Genital Herpes
Shingles

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Famciclovir plant distribution, commercial date of Famciclovir, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Famciclovir introduction, etc. Famciclovir Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Famciclovir
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Famciclovir Product Introduction
1.2 Market by Type
1.2.1 Global Famciclovir Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 125 mg Tablets
1.2.3 250 mg Tablets
1.2.4 500 mg Tablets
1.3 Market by Application
1.3.1 Global Famciclovir Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cold Sores
1.3.3 Genital Herpes
1.3.4 Shingles
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Famciclovir Sales Estimates and Forecasts 2018-2029
2.2 Global Famciclovir Revenue by Region
2.2.1 Global Famciclovir Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Famciclovir Revenue by Region (2018-2024)
2.2.3 Global Famciclovir Revenue by Region (2024-2029)
2.2.4 Global Famciclovir Revenue Market Share by Region (2018-2029)
2.3 Global Famciclovir Sales Estimates and Forecasts 2018-2029
2.4 Global Famciclovir Sales by Region
2.4.1 Global Famciclovir Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Famciclovir Sales by Region (2018-2024)
2.4.3 Global Famciclovir Sales by Region (2024-2029)
2.4.4 Global Famciclovir Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Famciclovir Sales by Manufacturers
3.1.1 Global Famciclovir Sales by Manufacturers (2018-2024)
3.1.2 Global Famciclovir Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Famciclovir in 2022
3.2 Global Famciclovir Revenue by Manufacturers
3.2.1 Global Famciclovir Revenue by Manufacturers (2018-2024)
3.2.2 Global Famciclovir Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Famciclovir Revenue in 2022
3.3 Global Key Players of Famciclovir, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Famciclovir Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Famciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Famciclovir, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Famciclovir, Product Offered and Application
3.8 Global Key Manufacturers of Famciclovir, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Famciclovir Sales by Type
4.1.1 Global Famciclovir Historical Sales by Type (2018-2024)
4.1.2 Global Famciclovir Forecasted Sales by Type (2024-2029)
4.1.3 Global Famciclovir Sales Market Share by Type (2018-2029)
4.2 Global Famciclovir Revenue by Type
4.2.1 Global Famciclovir Historical Revenue by Type (2018-2024)
4.2.2 Global Famciclovir Forecasted Revenue by Type (2024-2029)
4.2.3 Global Famciclovir Revenue Market Share by Type (2018-2029)
4.3 Global Famciclovir Price by Type
4.3.1 Global Famciclovir Price by Type (2018-2024)
4.3.2 Global Famciclovir Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Famciclovir Sales by Application
5.1.1 Global Famciclovir Historical Sales by Application (2018-2024)
5.1.2 Global Famciclovir Forecasted Sales by Application (2024-2029)
5.1.3 Global Famciclovir Sales Market Share by Application (2018-2029)
5.2 Global Famciclovir Revenue by Application
5.2.1 Global Famciclovir Historical Revenue by Application (2018-2024)
5.2.2 Global Famciclovir Forecasted Revenue by Application (2024-2029)
5.2.3 Global Famciclovir Revenue Market Share by Application (2018-2029)
5.3 Global Famciclovir Price by Application
5.3.1 Global Famciclovir Price by Application (2018-2024)
5.3.2 Global Famciclovir Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Famciclovir Market Size by Type
6.1.1 US & Canada Famciclovir Sales by Type (2018-2029)
6.1.2 US & Canada Famciclovir Revenue by Type (2018-2029)
6.2 US & Canada Famciclovir Market Size by Application
6.2.1 US & Canada Famciclovir Sales by Application (2018-2029)
6.2.2 US & Canada Famciclovir Revenue by Application (2018-2029)
6.3 US & Canada Famciclovir Market Size by Country
6.3.1 US & Canada Famciclovir Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Famciclovir Sales by Country (2018-2029)
6.3.3 US & Canada Famciclovir Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Famciclovir Market Size by Type
7.1.1 Europe Famciclovir Sales by Type (2018-2029)
7.1.2 Europe Famciclovir Revenue by Type (2018-2029)
7.2 Europe Famciclovir Market Size by Application
7.2.1 Europe Famciclovir Sales by Application (2018-2029)
7.2.2 Europe Famciclovir Revenue by Application (2018-2029)
7.3 Europe Famciclovir Market Size by Country
7.3.1 Europe Famciclovir Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Famciclovir Sales by Country (2018-2029)
7.3.3 Europe Famciclovir Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Famciclovir Market Size
8.1.1 China Famciclovir Sales (2018-2029)
8.1.2 China Famciclovir Revenue (2018-2029)
8.2 China Famciclovir Market Size by Application
8.2.1 China Famciclovir Sales by Application (2018-2029)
8.2.2 China Famciclovir Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Famciclovir Market Size by Type
9.1.1 Asia Famciclovir Sales by Type (2018-2029)
9.1.2 Asia Famciclovir Revenue by Type (2018-2029)
9.2 Asia Famciclovir Market Size by Application
9.2.1 Asia Famciclovir Sales by Application (2018-2029)
9.2.2 Asia Famciclovir Revenue by Application (2018-2029)
9.3 Asia Famciclovir Sales by Region
9.3.1 Asia Famciclovir Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Famciclovir Revenue by Region (2018-2029)
9.3.3 Asia Famciclovir Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Famciclovir Market Size by Type
10.1.1 Middle East, Africa and Latin America Famciclovir Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Famciclovir Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Famciclovir Market Size by Application
10.2.1 Middle East, Africa and Latin America Famciclovir Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Famciclovir Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Famciclovir Sales by Country
10.3.1 Middle East, Africa and Latin America Famciclovir Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Famciclovir Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Famciclovir Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Mylan
11.2.1 Mylan Company Information
11.2.2 Mylan Overview
11.2.3 Mylan Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Mylan Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Cipla
11.4.1 Cipla Company Information
11.4.2 Cipla Overview
11.4.3 Cipla Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Cipla Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cipla Recent Developments
11.5 Hikma
11.5.1 Hikma Company Information
11.5.2 Hikma Overview
11.5.3 Hikma Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Hikma Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hikma Recent Developments
11.6 Apotex
11.6.1 Apotex Company Information
11.6.2 Apotex Overview
11.6.3 Apotex Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Apotex Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Apotex Recent Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Overview
11.7.3 Aurobindo Pharma Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Aurobindo Pharma Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aurobindo Pharma Recent Developments
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Information
11.8.2 Macleods Pharmaceuticals Overview
11.8.3 Macleods Pharmaceuticals Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Macleods Pharmaceuticals Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Macleods Pharmaceuticals Recent Developments
11.9 Beijing Jialin Pharmaceutical
11.9.1 Beijing Jialin Pharmaceutical Company Information
11.9.2 Beijing Jialin Pharmaceutical Overview
11.9.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Beijing Jialin Pharmaceutical Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Beijing Jialin Pharmaceutical Recent Developments
11.10 HETERO
11.10.1 HETERO Company Information
11.10.2 HETERO Overview
11.10.3 HETERO Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 HETERO Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 HETERO Recent Developments
11.11 Hainan choitec Pharmaceuticals
11.11.1 Hainan choitec Pharmaceuticals Company Information
11.11.2 Hainan choitec Pharmaceuticals Overview
11.11.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Hainan choitec Pharmaceuticals Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hainan choitec Pharmaceuticals Recent Developments
11.12 Shandong Luoxin Pharmaceutical Group
11.12.1 Shandong Luoxin Pharmaceutical Group Company Information
11.12.2 Shandong Luoxin Pharmaceutical Group Overview
11.12.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Shandong Luoxin Pharmaceutical Group Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shandong Luoxin Pharmaceutical Group Recent Developments
11.13 Chengdu Diao Pharmaceutical Group
11.13.1 Chengdu Diao Pharmaceutical Group Company Information
11.13.2 Chengdu Diao Pharmaceutical Group Overview
11.13.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Chengdu Diao Pharmaceutical Group Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Chengdu Diao Pharmaceutical Group Recent Developments
11.14 HISUN
11.14.1 HISUN Company Information
11.14.2 HISUN Overview
11.14.3 HISUN Famciclovir Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 HISUN Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 HISUN Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Famciclovir Industry Chain Analysis
12.2 Famciclovir Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Famciclovir Production Mode & Process
12.4 Famciclovir Sales and Marketing
12.4.1 Famciclovir Sales Channels
12.4.2 Famciclovir Distributors
12.5 Famciclovir Customers
13 Market Dynamics
13.1 Famciclovir Industry Trends
13.2 Famciclovir Market Drivers
13.3 Famciclovir Market Challenges
13.4 Famciclovir Market Restraints
14 Key Findings in The Global Famciclovir Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Famciclovir Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 125 mg Tablets
Table 3. Major Manufacturers of 250 mg Tablets
Table 4. Major Manufacturers of 500 mg Tablets
Table 5. Global Famciclovir Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Famciclovir Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Famciclovir Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Famciclovir Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Famciclovir Revenue Market Share by Region (2018-2024)
Table 10. Global Famciclovir Revenue Market Share by Region (2024-2029)
Table 11. Global Famciclovir Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Famciclovir Sales by Region (2018-2024) & (K Units)
Table 13. Global Famciclovir Sales by Region (2024-2029) & (K Units)
Table 14. Global Famciclovir Sales Market Share by Region (2018-2024)
Table 15. Global Famciclovir Sales Market Share by Region (2024-2029)
Table 16. Global Famciclovir Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Famciclovir Sales Share by Manufacturers (2018-2024)
Table 18. Global Famciclovir Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Famciclovir Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Famciclovir, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Famciclovir Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Famciclovir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Famciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Famciclovir as of 2022)
Table 24. Global Key Manufacturers of Famciclovir, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Famciclovir, Product Offered and Application
Table 26. Global Key Manufacturers of Famciclovir, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Famciclovir Sales by Type (2018-2024) & (K Units)
Table 29. Global Famciclovir Sales by Type (2024-2029) & (K Units)
Table 30. Global Famciclovir Sales Share by Type (2018-2024)
Table 31. Global Famciclovir Sales Share by Type (2024-2029)
Table 32. Global Famciclovir Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Famciclovir Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Famciclovir Revenue Share by Type (2018-2024)
Table 35. Global Famciclovir Revenue Share by Type (2024-2029)
Table 36. Famciclovir Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Famciclovir Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Famciclovir Sales by Application (2018-2024) & (K Units)
Table 39. Global Famciclovir Sales by Application (2024-2029) & (K Units)
Table 40. Global Famciclovir Sales Share by Application (2018-2024)
Table 41. Global Famciclovir Sales Share by Application (2024-2029)
Table 42. Global Famciclovir Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Famciclovir Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Famciclovir Revenue Share by Application (2018-2024)
Table 45. Global Famciclovir Revenue Share by Application (2024-2029)
Table 46. Famciclovir Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Famciclovir Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Famciclovir Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Famciclovir Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Famciclovir Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Famciclovir Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Famciclovir Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Famciclovir Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Famciclovir Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Famciclovir Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Famciclovir Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Famciclovir Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Famciclovir Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Famciclovir Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Famciclovir Sales by Country (2024-2029) & (K Units)
Table 61. Europe Famciclovir Sales by Type (2018-2024) & (K Units)
Table 62. Europe Famciclovir Sales by Type (2024-2029) & (K Units)
Table 63. Europe Famciclovir Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Famciclovir Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Famciclovir Sales by Application (2018-2024) & (K Units)
Table 66. Europe Famciclovir Sales by Application (2024-2029) & (K Units)
Table 67. Europe Famciclovir Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Famciclovir Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Famciclovir Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Famciclovir Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Famciclovir Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Famciclovir Sales by Country (2018-2024) & (K Units)
Table 73. Europe Famciclovir Sales by Country (2024-2029) & (K Units)
Table 74. China Famciclovir Sales by Type (2018-2024) & (K Units)
Table 75. China Famciclovir Sales by Type (2024-2029) & (K Units)
Table 76. China Famciclovir Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Famciclovir Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Famciclovir Sales by Application (2018-2024) & (K Units)
Table 79. China Famciclovir Sales by Application (2024-2029) & (K Units)
Table 80. China Famciclovir Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Famciclovir Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Famciclovir Sales by Type (2018-2024) & (K Units)
Table 83. Asia Famciclovir Sales by Type (2024-2029) & (K Units)
Table 84. Asia Famciclovir Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Famciclovir Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Famciclovir Sales by Application (2018-2024) & (K Units)
Table 87. Asia Famciclovir Sales by Application (2024-2029) & (K Units)
Table 88. Asia Famciclovir Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Famciclovir Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Famciclovir Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Famciclovir Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Famciclovir Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Famciclovir Sales by Region (2018-2024) & (K Units)
Table 94. Asia Famciclovir Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Famciclovir Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Famciclovir Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Famciclovir Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Famciclovir Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Famciclovir Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Famciclovir Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Famciclovir Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Famciclovir Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Famciclovir Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Famciclovir Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Famciclovir Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Famciclovir Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Famciclovir Sales by Country (2024-2029) & (K Units)
Table 108. Novartis Company Information
Table 109. Novartis Description and Major Businesses
Table 110. Novartis Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Novartis Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Novartis Recent Developments
Table 113. Mylan Company Information
Table 114. Mylan Description and Major Businesses
Table 115. Mylan Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Mylan Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Mylan Recent Developments
Table 118. Teva Company Information
Table 119. Teva Description and Major Businesses
Table 120. Teva Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Teva Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Teva Recent Developments
Table 123. Cipla Company Information
Table 124. Cipla Description and Major Businesses
Table 125. Cipla Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Cipla Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Cipla Recent Developments
Table 128. Hikma Company Information
Table 129. Hikma Description and Major Businesses
Table 130. Hikma Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Hikma Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Hikma Recent Developments
Table 133. Apotex Company Information
Table 134. Apotex Description and Major Businesses
Table 135. Apotex Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Apotex Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Apotex Recent Developments
Table 138. Aurobindo Pharma Company Information
Table 139. Aurobindo Pharma Description and Major Businesses
Table 140. Aurobindo Pharma Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Aurobindo Pharma Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Aurobindo Pharma Recent Developments
Table 143. Macleods Pharmaceuticals Company Information
Table 144. Macleods Pharmaceuticals Description and Major Businesses
Table 145. Macleods Pharmaceuticals Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Macleods Pharmaceuticals Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Macleods Pharmaceuticals Recent Developments
Table 148. Beijing Jialin Pharmaceutical Company Information
Table 149. Beijing Jialin Pharmaceutical Description and Major Businesses
Table 150. Beijing Jialin Pharmaceutical Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Beijing Jialin Pharmaceutical Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Beijing Jialin Pharmaceutical Recent Developments
Table 153. HETERO Company Information
Table 154. HETERO Description and Major Businesses
Table 155. HETERO Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. HETERO Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. HETERO Recent Developments
Table 158. Hainan choitec Pharmaceuticals Company Information
Table 159. Hainan choitec Pharmaceuticals Description and Major Businesses
Table 160. Hainan choitec Pharmaceuticals Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Hainan choitec Pharmaceuticals Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Hainan choitec Pharmaceuticals Recent Developments
Table 163. Shandong Luoxin Pharmaceutical Group Company Information
Table 164. Shandong Luoxin Pharmaceutical Group Description and Major Businesses
Table 165. Shandong Luoxin Pharmaceutical Group Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Shandong Luoxin Pharmaceutical Group Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Shandong Luoxin Pharmaceutical Group Recent Developments
Table 168. Chengdu Diao Pharmaceutical Group Company Information
Table 169. Chengdu Diao Pharmaceutical Group Description and Major Businesses
Table 170. Chengdu Diao Pharmaceutical Group Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Chengdu Diao Pharmaceutical Group Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Chengdu Diao Pharmaceutical Group Recent Developments
Table 173. HISUN Company Information
Table 174. HISUN Description and Major Businesses
Table 175. HISUN Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. HISUN Famciclovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. HISUN Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Famciclovir Distributors List
Table 181. Famciclovir Customers List
Table 182. Famciclovir Market Trends
Table 183. Famciclovir Market Drivers
Table 184. Famciclovir Market Challenges
Table 185. Famciclovir Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Famciclovir Product Picture
Figure 2. Global Famciclovir Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Famciclovir Market Share by Type in 2022 & 2029
Figure 4. 125 mg Tablets Product Picture
Figure 5. 250 mg Tablets Product Picture
Figure 6. 500 mg Tablets Product Picture
Figure 7. Global Famciclovir Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Famciclovir Market Share by Application in 2022 & 2029
Figure 9. Cold Sores
Figure 10. Genital Herpes
Figure 11. Shingles
Figure 12. Famciclovir Report Years Considered
Figure 13. Global Famciclovir Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Famciclovir Revenue 2018-2029 (US$ Million)
Figure 15. Global Famciclovir Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Famciclovir Revenue Market Share by Region (2018-2029)
Figure 17. Global Famciclovir Sales 2018-2029 ((K Units)
Figure 18. Global Famciclovir Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Famciclovir Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Famciclovir Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Famciclovir Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Famciclovir Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Famciclovir Sales YoY (2018-2029) & (K Units)
Figure 24. China Famciclovir Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Famciclovir Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Famciclovir Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Famciclovir Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Famciclovir Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Famciclovir Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Famciclovir in the World: Market Share by Famciclovir Revenue in 2022
Figure 31. Global Famciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Famciclovir Sales Market Share by Type (2018-2029)
Figure 33. Global Famciclovir Revenue Market Share by Type (2018-2029)
Figure 34. Global Famciclovir Sales Market Share by Application (2018-2029)
Figure 35. Global Famciclovir Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Famciclovir Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Famciclovir Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Famciclovir Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Famciclovir Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Famciclovir Revenue Share by Country (2018-2029)
Figure 41. US & Canada Famciclovir Sales Share by Country (2018-2029)
Figure 42. U.S. Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Famciclovir Sales Market Share by Type (2018-2029)
Figure 45. Europe Famciclovir Revenue Market Share by Type (2018-2029)
Figure 46. Europe Famciclovir Sales Market Share by Application (2018-2029)
Figure 47. Europe Famciclovir Revenue Market Share by Application (2018-2029)
Figure 48. Europe Famciclovir Revenue Share by Country (2018-2029)
Figure 49. Europe Famciclovir Sales Share by Country (2018-2029)
Figure 50. Germany Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 51. France Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 55. China Famciclovir Sales Market Share by Type (2018-2029)
Figure 56. China Famciclovir Revenue Market Share by Type (2018-2029)
Figure 57. China Famciclovir Sales Market Share by Application (2018-2029)
Figure 58. China Famciclovir Revenue Market Share by Application (2018-2029)
Figure 59. Asia Famciclovir Sales Market Share by Type (2018-2029)
Figure 60. Asia Famciclovir Revenue Market Share by Type (2018-2029)
Figure 61. Asia Famciclovir Sales Market Share by Application (2018-2029)
Figure 62. Asia Famciclovir Revenue Market Share by Application (2018-2029)
Figure 63. Asia Famciclovir Revenue Share by Region (2018-2029)
Figure 64. Asia Famciclovir Sales Share by Region (2018-2029)
Figure 65. Japan Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 69. India Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Famciclovir Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Famciclovir Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Famciclovir Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Famciclovir Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Famciclovir Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Famciclovir Sales Share by Country (2018-2029)
Figure 76. Brazil Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Famciclovir Revenue (2018-2029) & (US$ Million)
Figure 81. Famciclovir Value Chain
Figure 82. Famciclovir Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries